Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-18-000054

Director bought 65,934 shares at $22.75 ($1,499,999)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-01-05 Purchase : show line 1 in the form +65,934 $22.75 $1,499,999 1,887,202 I
Open-market purchases · 65,934 sh · avg $22.75 · $1,499,999
Loading xslF345X03/crisprabefm4_jan52018.xml…